A class of drugs initially approved for diabetes treatment has captured the public’s and policymakers’ attention as interest in their off-label use for weight loss rises. The weight-loss benefits of these drugs have led to their prescribed use for obesity or overweight treatment. Increased off-label use of these drugs is contributing to supply shortages for … Continue reading How do prices of drugs for weight loss in the U.S. compare to peer nations’ prices?